Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser with Tacrolimus, Calcipotriol or NB-UVB for Vitiligo
NCT03234673Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of Tacrolimus Ointment 0.1% Iwaki and AKP01 in generalized vitiligo (3 arms), sponsored by Assiut University. Primary endpoint: Re-pigmentation at 3 months. Status: unknown.
02
Drugs
Tacrolimus Ointment 0.1% IwakiAKP01
03
Conditions
generalized vitiligo
Beyond the preview
Go deeper on NCT03234673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234673.